HomeCompareSLGC vs VICI

SLGC vs VICI: Dividend Comparison 2026

SLGC yields 95.24% · VICI yields 5.88%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SLGC wins by $3.17M in total portfolio value
10 years
SLGC
SLGC
● Live price
95.24%
Share price
$2.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.20M
Annual income
$1,043,960.64
Full SLGC calculator →
VICI
VICI Properties Inc.
● Live price
5.88%
Share price
$28.90
Annual div
$1.70
5Y div CAGR
8.1%
Payout ratio
74%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$2,376.06
Full VICI calculator →

Portfolio growth — SLGC vs VICI

📍 SLGC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLGCVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLGC + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SLGC pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLGC
Annual income on $10K today (after 15% tax)
$8,095.24/yr
After 10yr DRIP, annual income (after tax)
$887,366.54/yr
VICI
Annual income on $10K today (after 15% tax)
$500.00/yr
After 10yr DRIP, annual income (after tax)
$2,019.65/yr
At 15% tax rate, SLGC beats the other by $885,346.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLGC + VICI for your $10,000?

SLGC: 50%VICI: 50%
100% VICI50/50100% SLGC
Portfolio after 10yr
$1.62M
Annual income
$523,168.35/yr
Blended yield
32.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

SLGC
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Price Target
$12.00
+471.4% upside vs current
Range: $9.00 — $15.00
Altman Z
2.1
Piotroski
2/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+9.3% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLGC buys
0
VICI buys
0
No recent congressional trades found for SLGC or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLGCVICI
Forward yield95.24%5.88%
Annual dividend / share$2.00$1.70
Payout ratio50%74%
1-year div growth0%6.3%
5-year div CAGR0%8.1%
Portfolio after 10y$3.20M$30.3K
Annual income after 10y$1,043,960.64$2,376.06
Total dividends collected$2.84M$13.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$12.00$31.60

Year-by-year: SLGC vs VICI ($10,000, DRIP)

YearSLGC PortfolioSLGC Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$20,224$9,523.81$11,056$635.88+$9.2KSLGC
2$39,640$18,000.72$12,250$729.34+$27.4KSLGC
3$75,390$32,974.56$13,602$838.33+$61.8KSLGC
4$139,277$58,609.85$15,139$965.75+$124.1KSLGC
5$250,220$101,193.83$16,890$1,115.11+$233.3KSLGC
6$437,643$169,907.92$18,890$1,290.64+$418.8KSLGC
7$746,012$277,733.46$21,181$1,497.50+$724.8KSLGC
8$1,240,688$442,455.79$23,813$1,741.95+$1.22MSLGC
9$2,015,243$687,706.55$26,845$2,031.67+$1.99MSLGC
10$3,200,271$1,043,960.64$30,348$2,376.06+$3.17MSLGC

SLGC vs VICI: Complete Analysis 2026

SLGCStock

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.

Full SLGC Calculator →

VICIREIT

VICI Properties is a gaming and entertainment REIT owning properties including Caesars Palace and MGM Grand in Las Vegas. Its triple-net leases with leading casino operators provide highly predictable income. VICI has grown its dividend 8%+ annually since its 2018 IPO, making it one of the fastest-growing REITs.

Full VICI Calculator →
📬

Get this SLGC vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLGC vs SCHDSLGC vs JEPISLGC vs OSLGC vs KOSLGC vs MAINSLGC vs NNNSLGC vs EPRTSLGC vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.